1. Home
  2. Labeler Index
  3. Teva Pharmaceuticals Usa, Inc.
  4. 0093-5955
  5. NDC Package Code: 0093-5955-56 Arformoterol Tartrate

NDC Package 0093-5955-56 Arformoterol Tartrate

Solution Respiratory (inhalation) - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0093-5955-56
Package Description:
30 POUCH in 1 CARTON / 1 AMPULE in 1 POUCH (0093-5955-11) / 2 mL in 1 AMPULE
Product Code:
0093-5955
Proprietary Name:
Arformoterol Tartrate
Non-Proprietary Name:
Arformoterol Tartrate
Substance Name:
Arformoterol Tartrate
Usage Information:
Arformoterol is used as a long-term (maintenance) treatment to prevent and decrease wheezing and shortness of breath caused by breathing problems (such as chronic obstructive pulmonary disease, including chronic bronchitis and emphysema). Arformoterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Arformoterol is also known as a bronchodilator. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication does not work right away and should not be used for sudden attacks of breathing trouble. Your doctor must prescribe a quick-relief medicine/inhaler (such as albuterol, also known as salbutamol) for sudden shortness of breath while you are using arformoterol. You should always have a quick-relief inhaler with you. Arformoterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as arformoterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems.
11-Digit NDC Billing Format:
00093595556
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 668956 - arformoterol tartrate 15 MCG in 2 ML Inhalation Solution
  • RxCUI: 668956 - arformoterol 0.0075 MG/ML Inhalation Solution
  • RxCUI: 668956 - arformoterol 0.0075 MG/ML (arformoterol tartrate 0.011 MG/ML) Inhalation Solution
  • RxCUI: 668956 - arformoterol 15 MCG per 2 ML Inhalation Solution
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Teva Pharmaceuticals Usa, Inc.
    Dosage Form:
    Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
    Administration Route(s):
  • Respiratory (inhalation) - Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.
    • Active Ingredient(s):
  • ARFORMOTEROL TARTRATE 15 ug/2mL
    • Pharmacologic Class(es):
  • Adrenergic beta2-Agonists - [MoA] (Mechanism of Action)
  • beta2-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    ANDA200293
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    12-06-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0093-5955-0612 POUCH in 1 CARTON / 5 AMPULE in 1 POUCH (0093-5955-45) / 2 mL in 1 AMPULE (0093-5955-19)

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0093-5955-56?

    The NDC Packaged Code 0093-5955-56 is assigned to a package of 30 pouch in 1 carton / 1 ampule in 1 pouch (0093-5955-11) / 2 ml in 1 ampule of Arformoterol Tartrate, a human prescription drug labeled by Teva Pharmaceuticals Usa, Inc.. The product's dosage form is solution and is administered via respiratory (inhalation) form.

    Is NDC 0093-5955 included in the NDC Directory?

    Yes, Arformoterol Tartrate with product code 0093-5955 is active and included in the NDC Directory. The product was first marketed by Teva Pharmaceuticals Usa, Inc. on December 06, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0093-5955-56?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 0093-5955-56?

    The 11-digit format is 00093595556. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20093-5955-565-4-200093-5955-56